CHK1 Inhibitors in Combination Chemotherapy
Multiple CHK1 inhibitors promote compensatory activation of the RAS-SRC / MEK1/2 / ERK1/2 pathway. The survival pathway can be inhibited at various points along its course that reveals the true toxicity of CHK1 inhibitor exposure. Killing is mediated via the intrinsic / mitochondrial cell death pathway.
Publication
CHK1 Inhibitors in Combination Chemotherapy. (2011) Paul Dent, et al. Mol Interv. 2011 Apr;11(2):133-140. Figure: F4.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | PARP1 | PARP1 | ncbigene_symbol | PARP1 | 142 |
| Homo sapiens | Primates | ATM | ATM | ncbigene_symbol | ATM | 472 |
| Homo sapiens | Primates | CHK1-ATM/ATR | ATR | ncbigene_symbol | ATR | 545 |
| Homo sapiens | Primates | CHK1-ATM/ATR | ATR | ncbigene_synonym | ANTXR1 | 84168 |
| Homo sapiens | Primates | CHK1-ATM/ATR | ATR | ncbigene_synonym | MMAB | 326625 |
| Homo sapiens | Primates | CHK1-ATM/ATR | ATR | ncbigene_synonym | SERPINA2 | 390502 |
| Homo sapiens | Primates | CHK1- | CHK1 | ncbigene_synonym | CHEK1 | 1111 |
| Homo sapiens | Primates | BAX | BAX | ncbigene_symbol | BAX | 581 |
| Homo sapiens | Primates | MCL-1 | MCL-1 | ncbigene_synonym | MCL1 | 4170 |
| Homo sapiens | Primates | BAK | BAK | ncbigene_synonym | BAK1 | 578 |
| Homo sapiens | Primates | SRC | SRC | ncbigene_symbol | SRC | 6714 |
| Homo sapiens | Primates | SRC | SRC | famplex_relations | FGR | 2268 |
| Homo sapiens | Primates | SRC | SRC | famplex_relations | FYN | 2534 |
| Homo sapiens | Primates | SRC | SRC | famplex_relations | YES1 | 7525 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | KRAS | 3845 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | HRAS | 3265 |
| Homo sapiens | Primates | RAS | RAS | famplex_relations | NRAS | 4893 |
| Homo sapiens | Primates | RAF-1 | RAF-1 | ncbigene_synonym | RAF1 | 5894 |
| Homo sapiens | Primates | Apaf-1 | APAF-1 | ncbigene_synonym | APAF1 | 317 |
| Homo sapiens | Primates | MEK1 | MEK1 | ncbigene_synonym | MAP2K1 | 5604 |
| Homo sapiens | Primates | MEK1/2 | MEK2 | ncbigene_synonym | MAP2K2 | 5605 |
| Homo sapiens | Primates | ERK1 | ERK1 | ncbigene_synonym | MAPK3 | 5595 |
| Homo sapiens | Primates | ERK1/2 | ERK2 | ncbigene_synonym | MAPK1 | 5594 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| R115777 | tipifarnib | mesh:C402769 | tipifarnib | chebi:141969 |
| Tipifarnib | tipifarnib | mesh:C402769 | tipifarnib | chebi:141969 |
| AZD0530 | saracatinib | mesh:C515233 | saracatinib | chebi:47458 |
| AZD6244 | selumetinib | mesh:C517975 | AZD 6244 | chebi:90227 |
| AZD2281 | olaparib | mesh:C531550 | olaparib | chebi:83766 |
| AZD7762 | NA | mesh:C532363 | ||
| PF-477736 | NA | mesh:C532366 | ||
| SCH900776 | NA | mesh:C559815 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|---|---|---|---|
| Cancer | NA |